The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.60
Bid: 27.60
Ask: 27.90
Change: -0.30 (-1.08%)
Spread: 0.30 (1.087%)
Open: 27.05
High: 28.30
Low: 27.05
Prev. Close: 27.90
MARS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

7 Dec 2021 11:11

RNS Number : 8412U
Marston's PLC
07 December 2021
 

7 December 2021

 

Notification of interests of directors and persons discharging managerial responsibilities

 

Marston's PLC (the "Company") announces that on 6 December 2021 the Directors listed below were granted awards over ordinary shares in the Company under the Company's 2014 Long Term Incentive Plan (the "Plan"). The number of awards granted on 6 December 2021 was calculated using the market price at the close of trading on the London Stock Exchange on 3 December 2021, being £0.6705 per ordinary share.

 

Awards under the Plan are structured as Approved Performance Share Plan Awards ("APSP Awards") and comprise three elements: (i) an HMRC Tax Qualifying Option over shares with a total value at the date of grant of £30,000 with an exercise price of £0.6705 per share; (ii) a "Linked Award" which is, principally, a funding award in the form of a nil cost option (i.e. in the form of an LTIP Award) over such number of shares whose total value at exercise equals £30,000; and (iii) an LTIP Award in the form of a nil cost option over shares to the value of the remainder of the APSP Award above the £30,000 limit.

 

The awards will vest subject to the satisfaction of performance metrics which are based on Underlying Profit Before Tax (as regards 40% of the award), Net Cash Flow (as regards 40% of the award) and Relative Total Shareholder Return (as regards 20% of the award) assessed over the Company's 2021/22, 2022/23 and 2023/24 financial periods, details of which will be set out in the Company's Annual Report for the period ended 2 October 2021. To the extent an award vests, it will be released (so that the participant is entitled to acquire the shares) following the end of a further two-year holding period.

 

In addition to satisfaction of these performance conditions, the Tax Qualifying Option will only become exercisable if the market value of a share at exercise is greater than 67.05 pence per share. If the market value at exercise is less than £0.6705 per share, the Tax Qualifying Option will lapse and the maximum number of shares subject to the Linked Award will become available to the participant to exercise as an unapproved LTIP option.

 

Appropriate provisions have been included in the terms of the awards to enable the Remuneration Committee to adjust the vesting outturn having regard to any "windfall gain".

 

 

Name

Designation

Number of shares subject to APSP Award (Tax Qualifying Option and LTIP Award)

Maximum number of Shares subject to Linked Award

Andrew Andrea

Director

1,123,322

44,742

Hayleigh Lupino

Director

720,078

44,742

 

 

 

 

Enquiries:

Anne-Marie Brennan, Group Secretary, Marston's PLC, +44 (0) 1902 329163

 

 

Notification of Dealing Form

 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")

a)

Name

Andrew Andrea

 

2.

Reason for the notification

a)

Position/status

Director and PDMR (Chief Executive Officer)

 

b)

Initial notification/ amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Marston's PLC

b)

LEI code

213800Q6RP3ZJ2CZR962

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification code

Ordinary Shares of 7.375 pence each

 

 

ISIN: GB00B1JQDM80

b)

Nature of the transaction

Grant of award under the Long Term Incentive Plan in the form of nil-cost options and a Tax Qualifying Option at an exercise price of £0.6705 per share.

c)

Price(s) and volumes(s)

 

Price

Volume

Nil cost option: N/A

1,078,580

Tax Qualifying Option: N/A

44,742

d)

Aggregated information

- Aggregate volume

 

- Price

 

 

N/A

 

e)

Date of the transaction

2021-12-06

f)

Place of the transaction

Outside a trading venue

 

 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")

a)

Name

Hayleigh Lupino

 

2.

Reason for the notification

a)

Position/status

Director and PDMR (Chief Financial Officer)

 

b)

Initial notification/

amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Marston's PLC

b)

LEI code

213800Q6RP3ZJ2CZR962

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification code

Ordinary Shares of 7.375 pence each

 

 

ISIN: GB00B1JQDM80

b)

Nature of the transaction

Grant of award under the Long Term Incentive Plan in the form of nil-cost options and a Tax Qualifying Option at an exercise price of £0.6507 per share.

c)

Price(s) and volumes(s)

 

Price

Volume

Nil cost option: N/A

675,336

Tax Qualifying Option: N/A

44,742

d)

Aggregated information

- Aggregate volume

 

- Price

 

 

N/A

 

e)

Date of the transaction

2021-12-06

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAFAXEEPFFFA
Date   Source Headline
28th Nov 202212:55 pmRNSChange to Final Results date and update on trading
28th Nov 20229:59 amRNSHolding(s) in Company
25th Nov 202212:04 pmRNSHolding(s) in Company
17th Nov 20229:14 amRNSHolding(s) in Company
17th Nov 20227:09 amRNSDirector Declaration re: New Directorship
10th Nov 202210:47 amRNSHolding(s) in Company
9th Nov 20228:15 amRNSHolding(s) in Company
3rd Nov 20224:25 pmRNSHolding(s) in Company
3rd Nov 20223:05 pmRNSHolding(s) in Company
11th Oct 20227:00 amRNSTrading update for the 52 weeks to 1 October 2022
6th Oct 20229:31 amRNSCorrection re Holding(s) in Company
5th Oct 202212:15 pmRNSHolding(s) in Company
12th Sep 20229:43 amRNSDirector/PDMR Shareholding
5th Sep 202212:27 pmRNSDirector/PDMR Shareholding
2nd Sep 202210:14 amRNSDirector/PDMR Shareholding
31st Aug 20222:51 pmRNSHolding(s) in Company
27th Jul 20227:00 amRNSTrading update for the 42 weeks to 23 July 2022
11th Jul 202212:03 pmRNSBlock listing Interim Review
7th Jul 20229:55 amRNSHolding(s) in Company
29th Jun 20228:45 amRNSDirector/PDMR Shareholding
13th Jun 20228:30 amRNSDirector/PDMR Shareholding
30th May 20222:14 pmRNSHolding(s) in Company
25th May 20228:54 amRNSHolding(s) in Company
20th May 202210:15 amRNSDirector/PDMR Shareholding
19th May 20227:00 amRNSInvestor Meet Company Presentation
18th May 20227:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 2 APRIL 2022
5th Apr 202212:39 pmRNSHolding(s) in Company
30th Mar 20228:28 amRNSDirector/PDMR Shareholding
28th Mar 20229:49 amRNSHolding(s) in Company
17th Mar 202210:18 amRNSHolding(s) in Company
8th Mar 202210:06 amRNSHolding(s) in Company
7th Mar 20227:00 amRNSDirectorate Change
3rd Mar 20229:45 amRNSHolding(s) in Company
18th Feb 20221:09 pmRNSHolding(s) in Company
25th Jan 20222:35 pmRNSTrading for the period to 22 Jan 2022 - Correction
25th Jan 20222:20 pmRNSResult of AGM
25th Jan 20227:00 amRNSTrading for the 16-week period to 22 January 2022
10th Jan 20223:55 pmRNSBlock listing Interim Review
20th Dec 20214:15 pmRNSAnnual Financial Report
7th Dec 202111:11 amRNSDirector/PDMR Shareholding
30th Nov 20217:00 amRNSRESULTS FOR THE 52 WEEKS ENDED 2 OCTOBER 2021
19th Oct 20219:05 amRNSHolding(s) in Company
13th Oct 20217:00 amRNSYear end trading update
30th Sep 202110:43 amRNSDisclosure of 2020/21 LTIP performance targets
16th Sep 20213:00 pmRNSDirector Declaration re: New Directorship
9th Sep 20212:30 pmRNSDirector/PDMR Shareholding
28th Jul 20217:00 amRNSTrading Update
20th Jul 20217:08 amRNSDirectorate Change
13th Jul 20218:36 amRNSBlock listing Interim Review
6th Jul 20217:00 amRNSAppointment of Chief Financial Officer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.